[go: up one dir, main page]

FI885628A0 - Immobiliserat interleukin-2 och interleukin-2 med karboxylterminalfoerlaengning. - Google Patents

Immobiliserat interleukin-2 och interleukin-2 med karboxylterminalfoerlaengning.

Info

Publication number
FI885628A0
FI885628A0 FI885628A FI885628A FI885628A0 FI 885628 A0 FI885628 A0 FI 885628A0 FI 885628 A FI885628 A FI 885628A FI 885628 A FI885628 A FI 885628A FI 885628 A0 FI885628 A0 FI 885628A0
Authority
FI
Finland
Prior art keywords
interleukin
karboxylterminalfoerlaengning
immobilizers
och
med
Prior art date
Application number
FI885628A
Other languages
English (en)
Other versions
FI885628A (fi
Inventor
Vries Yuan Lin De
Richard John Robb
Paul Simon
Charles Thayer White
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of FI885628A0 publication Critical patent/FI885628A0/fi
Publication of FI885628A publication Critical patent/FI885628A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • C12N5/0638Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/2302Interleukin-2 (IL-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI885628A 1987-12-04 1988-12-02 Immobiliserat interleukin-2 och interleukin-2 med karboxylterminalfoerlaengning. FI885628A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12893187A 1987-12-04 1987-12-04

Publications (2)

Publication Number Publication Date
FI885628A0 true FI885628A0 (fi) 1988-12-02
FI885628A FI885628A (fi) 1989-06-05

Family

ID=22437677

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885628A FI885628A (fi) 1987-12-04 1988-12-02 Immobiliserat interleukin-2 och interleukin-2 med karboxylterminalfoerlaengning.

Country Status (11)

Country Link
EP (1) EP0319012A3 (fi)
JP (1) JPH02300A (fi)
KR (1) KR890009978A (fi)
AU (1) AU2635088A (fi)
DK (1) DK673788A (fi)
FI (1) FI885628A (fi)
HU (1) HUT50506A (fi)
IL (1) IL88565A0 (fi)
NO (1) NO885389L (fi)
PT (1) PT89121A (fi)
ZA (1) ZA888978B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229272A (en) * 1989-04-25 1993-07-20 Igen, Inc. Catalytic antibody components
EP0460101A4 (en) * 1989-02-24 1992-04-15 Immunotherapeutics, Inc. Immobilized cytokines
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0406857B1 (en) * 1989-07-07 1995-05-24 Takeda Chemical Industries, Ltd. Proteins and production thereof
FR2653020B1 (fr) * 1989-10-17 1993-03-26 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
AU657910B2 (en) * 1990-07-05 1995-03-30 Akzo N.V. Receptor directed-toxin conjugates
FR2666898A1 (fr) * 1990-09-18 1992-03-20 Toledano Jacques Dispositif et procede de dosage rapide de recepteurs membranaires ou de leurs ligands.
US6072039A (en) * 1991-04-19 2000-06-06 Rohm And Haas Company Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
US5635597A (en) * 1994-05-27 1997-06-03 Affymax Technologies, N.V. Peptides that bind IL-2 receptors
FR2764988B1 (fr) * 1997-06-20 1999-07-23 Bio Merieux Compose conjugue, reactif et kit le contenant, et utilisations dans un procede de fixation d'un materiel biologique
CA2693296C (en) 1997-12-08 2013-09-10 Merck Patent Gmbh Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
RU2263118C2 (ru) 1999-08-09 2005-10-27 Лексиген Фармасьютикэлс Корп. Комплексы антител с несколькими цитокинами
CA2399832C (en) 2000-02-11 2011-09-20 Stephen D. Gillies Enhancing the circulating half-life of antibody-based fusion proteins
EP1366067B1 (en) 2001-03-07 2012-09-26 Merck Patent GmbH Expression technology for proteins containing a hybrid isotype antibody moiety
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
CN100503639C (zh) 2001-05-03 2009-06-24 默克专利有限公司 重组肿瘤特异性抗体及其应用
FR2832508A1 (fr) * 2001-11-21 2003-05-23 Bio Merieux Procede d'obtention d'une phase de capture et d'une phase de detection d'un materiel biologique cible et utilisation dans des tests elisa
EP2354791A1 (en) 2001-12-04 2011-08-10 Merck Patent GmbH Immunocytokines with modulated selectivity
AU2003298187B2 (en) 2002-12-17 2010-09-16 Merck Patent Gmbh Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with IL-2
PT2573166T (pt) 2004-02-26 2016-07-07 Immunovative Therapies Ltd Métodos para preparar células-t para terapia celular
US7592431B2 (en) * 2004-02-26 2009-09-22 Immunovative Therapies, Ltd. Biodegradable T-cell Activation device
CN100391726C (zh) * 2006-04-28 2008-06-04 江阴市万事达液压机械有限公司 缸体破碎机
KR20120093002A (ko) * 2011-02-14 2012-08-22 (주)에이티젠 Nk 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
AU2012250794B2 (en) 2011-05-03 2015-11-05 Immunovative Therapies, Ltd. Methods for handling biological drugs containing living cells
AU2012250807A1 (en) 2011-05-03 2013-12-12 Immunovative Therapies, Ltd. Induction of IL-12 using immunotherapy
JP2021533183A (ja) * 2018-07-13 2021-12-02 アイエル−2アールエックス インコーポレイテッド がんおよび免疫障害を治療するための化合物、組成物、方法および使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
US4703004A (en) * 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
JPS6153300A (ja) * 1984-08-23 1986-03-17 Takeda Chem Ind Ltd 固定化インタ−ロイキン−2
JPS61277628A (ja) * 1985-06-04 1986-12-08 Asahi Chem Ind Co Ltd 癌治療用白血球刺激材

Also Published As

Publication number Publication date
IL88565A0 (en) 1989-07-31
FI885628A (fi) 1989-06-05
NO885389L (no) 1989-06-05
ZA888978B (en) 1990-07-25
EP0319012A3 (en) 1990-05-16
JPH02300A (ja) 1990-01-05
KR890009978A (ko) 1989-08-05
AU2635088A (en) 1989-06-08
EP0319012A2 (en) 1989-06-07
HUT50506A (en) 1990-02-28
NO885389D0 (no) 1988-12-02
PT89121A (pt) 1989-12-29
DK673788D0 (da) 1988-12-02
DK673788A (da) 1989-06-05

Similar Documents

Publication Publication Date Title
FI885628A0 (fi) Immobiliserat interleukin-2 och interleukin-2 med karboxylterminalfoerlaengning.
FI874278A (fi) Emaljkomposition och med denna belagda underlag.
FI885987A (fi) Med skyddsanordning och faestanordning foersedd elektrisk kopplingsanordning.
FI893945A0 (fi) Skaernings- och oeppningsfoerfarande och anordning foer rektangulaera foerpackningar oeverdragna med foerpackningsmaterial.
FI871550A (fi) Foerfarande och bioreaktor foer behandling av laogaktivt organiskt avfall fraon kaernkraftverk med hjaelp av anaerobisk jaesning.
FI882130A0 (fi) Platinakomplex med tumoermotverkande effekt, deras framstaellning och terapeutisk anvaendning.
FI890745A0 (fi) Kyltorn med laog silhuett och med fyllstrut med trapetsform.
FI86238B (fi) Televisionsapparat och televisionsapparats effektkaella.
FI882803A0 (fi) Oljekompositioner med foerhoejd viskositet och foerfarande foer deras framstaellning.
DE3887899D1 (de) Regelbarer oszillator.
FI885073A0 (fi) Fotohaerdbar elektrostatisk tryckskiva med foerbaettrad aotergaong och laddningsreduktion.
FI881672A0 (fi) Oevergaongsmotstaondsmaetare och med denna anvaendbar avkaenningsnaol.
FI882774A (fi) Kopplingsanordning foer en centralstyrd telekommunikationsanlaeggning, saerskilt en pcm-telefoncentral, med en centraldel och med denna foerbundna anslutningsgrupper.
FI890149A0 (fi) Klippkrest foer effektransistorkrets och en med detsamma foersedd vaexelriktare.
FI884354A (fi) Gavelvaeggskonstruktion med loestagbar skiva och saekerhetsegenskaper.
FI895988A0 (fi) Oligomera polyestrar och polyamider med dipiperidyltriazingrupper.
FI892862A0 (fi) Foerbraenningsmotormaskin med flera cylindrar och avgasledning.
FI881807A0 (fi) Foerfarande och anordning foer matning av dragkedja med sprundflikar.
FI873361A (fi) Kombination av lyftfoerflyttningsvagn och kopplingsanordning foer anvaendning tillsammans med dragmaskin.
FI872972A0 (fi) Skarvhylsa foer slagpaolar och pelare med slutet tvaersnitt.
FI874935A0 (fi) Fasadelement med naturstensyta och metallstomme.
FI874651A0 (fi) Foerfarande och anordning i en inloppslaoda med haolvals.
FI890468A0 (fi) Utomhusbelysningsarmatur med kupformig stomme och ljusgenomslaepplig kupa.
FI881138A0 (fi) Motorkaelke med fjaedrande stomme och boggie.
FI883893A0 (fi) Aemne och laoda med god staplingshaollfasthet.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: E.I. DU PONT DE NEMOURS AND COMPANY